APA (7th ed.) Citation

F, L., N, M., Y, J., L, B., M, B., M, L., . . . D, S. (2018). GEMO, a National Resource to Study Genetic Modifiers of Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Pathogenic Variant Carriers. Frontiers in oncology, 8, 490. https://doi.org/10.3389/fonc.2018.00490

Chicago Style (17th ed.) Citation

F, Lesueur, et al. "GEMO, a National Resource to Study Genetic Modifiers of Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Pathogenic Variant Carriers." Frontiers in Oncology 8 (2018): 490. https://doi.org/10.3389/fonc.2018.00490.

MLA (9th ed.) Citation

F, Lesueur, et al. "GEMO, a National Resource to Study Genetic Modifiers of Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Pathogenic Variant Carriers." Frontiers in Oncology, vol. 8, 2018, p. 490, https://doi.org/10.3389/fonc.2018.00490.